Option Care Health (NASDAQ:OPCH) Downgraded by The Goldman Sachs Group to “Neutral”

The Goldman Sachs Group cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a neutral rating in a report issued on Monday morning, Marketbeat reports. They currently have $27.00 price objective on the stock, down from their previous price objective of $38.00.

Several other analysts have also commented on the stock. Barrington Research reduced their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Price Performance

Option Care Health stock opened at $23.50 on Monday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a 50-day moving average price of $30.14 and a 200 day moving average price of $29.79. Option Care Health has a 12-month low of $22.25 and a 12-month high of $34.63. The stock has a market cap of $4.00 billion, a P/E ratio of 19.75, a PEG ratio of 2.33 and a beta of 1.32.

Insiders Place Their Bets

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OPCH. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares in the last quarter. GAMMA Investing LLC boosted its stake in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the last quarter. Finally, SageView Advisory Group LLC purchased a new stake in shares of Option Care Health in the 1st quarter valued at about $85,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.